TRAFIC:类风湿关节炎实用早期1/2期贝叶斯自适应剂量递增试验的统计设计与分析计划
TRAFIC是一项在类风湿关节炎中开展的多中心早期试验,采用贝叶斯自适应剂量寻找I期滚动进入单臂单阶段II期的设计。I期模型参数通过蒙特卡洛模拟在临床相关场景下评估客观性能指标并纳入提前终止的停止规则,还利用剂量过渡路径进一步校准设计。该试验由MRC资助,是炎症性疾病中首个获资助的基于模型的剂量寻找试验,表明在非癌症人群中设计、资助和实施此类试验在常规科研资助轨道和监管约束内是可行的。
要点
- TRAFIC采用贝叶斯自适应剂量寻找I期滚动进入单臂单阶段II期的设计。
- I期设计允许借用既往试验信息,所有累积数据用于决策。
- 该试验是炎症性疾病中首个获资助的基于模型的剂量寻找试验。
核心结论
- TRAFIC表明在非癌症人群中设计、资助和实施基于模型的I期试验在常规科研资助轨道和监管约束内是可行的。
- TRAFIC是炎症性疾病中首个获资助的基于模型的剂量寻找试验,说明小型I/II期试验可为决策和解读提供统计基础。
研究设计与样本
- TRAFIC是一项在类风湿关节炎中开展的多中心早期试验,采用贝叶斯自适应剂量寻找I期滚动进入单臂单阶段II期试验的设计。
- I期模型参数通过蒙特卡洛模拟在临床相关场景下评估客观性能指标来选择,并纳入提前终止的停止规则。
- 候选设计利用剂量过渡路径进一步校准。
主要发现
- I期设计允许借用既往试验信息,所有累积数据用于决策。
- 通过模拟验证操作特征,并通过剂量过渡路径增进管理监督团队的理解。
- 滚动II期设计在试验实施包括站点和监查活动及成本方面带来效率。
临床怎么用
- TRAFIC的设计可为在非癌症人群中开展基于模型的早期剂量寻找试验提供参考。
- 剂量过渡路径可用于增进管理监督团队对自适应设计的理解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adaptive model-based dose-finding designs have demonstrated advantages over traditional rule-based designs but have increased statistical complexity but uptake has been slow especially outside of cancer trials. TRAFIC is a multi-centre, early phase trial in rheumatoid arthritis incorporating a model-based design. METHODS: A Bayesian adaptive dose-finding phase I trial rolling into a single-arm, single-stage phase II trial. Model parameters for phase I were chosen via Monte Carlo simulation evaluating objective performance measures under clinically relevant scenarios and incorporated stopping rules for early termination. Potential designs were further calibrated utilising dose transition pathways. DISCUSSION: TRAFIC is an MRC-funded trial of a re-purposed treatment demonstrating that it is possible to design, fund and implement a model-based phase I trial in a non-cancer population within conventional research funding tracks and regulatory constraints. The phase I design allows borrowing of information from previous trials, all accumulated data to be utilised in decision-making, verification of operating characteristics through simulation, improved understanding for management and oversight teams through dose transition pathways. The rolling phase II design brings efficiencies in trial conduct including site and monitoring activities and cost. TRAFIC is the first funded model-based dose-finding trial in inflammatory disease demonstrating that small phase I/II trials can have an underlying statistical basis for decision-making and interpretation. TRIAL REGISTRATION: Trials Registration: ISRCTN, ISRCTN36667085 . Registered on September 26, 2014.
引用
- Cole M, Yap C, Buckley C, et al. TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis. Trials. 2021. PMID: 34229728. doi:10.1186/s13063-021-05384-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。